MICHELLE MURRAY: Open Payments
NPI 1194143123 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,907 in 76 payments from 15 companies in 2025. Trend: 2023 $3,097 · 2024 $2,864 · 2025 $1,907
Food & beverage: $1,890Education: $17
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 13 | $381 |
| Verona Pharma, Inc. | 14 | $332 |
| Insmed, Inc. | 12 | $249 |
| AstraZeneca Pharmaceuticals LP | 5 | $204 |
| Axsome Therapeutics, Inc. | 7 | $177 |
| GlaxoSmithKline, LLC. | 10 | $162 |
| Galvanize Therapeutics, Inc | 1 | $127 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $113 |
| Amgen Inc. | 2 | $32 |
| Merck Sharp & Dohme LLC | 2 | $31 |
Products named: DUPIXENT, Ohtuvayre, Arikayce, Sunosi, TEZSPIRE, ALIYA SYSTEM, NUCALA, FASENRA.
Industry payments across WV — which companies pay providers there.
